Details
| Name | CDKN2B-AS1 |
| Type | lncRNA |
| Species | Homo sapiens |
| Tissue | cervical |
| Experiment Method | qRT-PCR,Luciferase reporter assay,Bgalactosidase senescence assays |
| Up/Down | Up |
| Pro/Anti | Pro |
| Funtion Description | LncRNA CDKN2B anti-sense RNA (CDKN2B-AS1, also named ANRIL, a 3.8-kb long noncoding RNA), has been verified to be upregulated in tumor tissue and function as a tumor-promoting lncRNA in numerous malignancies, such as hepatocellular carcinoma,non-small cel |
| Regulation Gene | miR-181a-5p |
| Year | 2019 |
| Pubmed ID | 30884187 |
| Title | Interference of the long noncoding RNA CDKN2B-AS1 upregulates miR-181a-5p/TGFBI axis to restrain the metastasis and promote apoptosis and senescence of cervical cancer cells. |
| Drug | NA |
| Disease | Cervical cancer |
| Environment Factors | NA |
| Circulating | NA |
| Variant | NA |
| High-throughput | NA |